Evidence map›Paper›PMID 42015248›Full record

ReviewJournal of neuroinflammation2026

Nociceptor neurons shape antiviral immunity.

Isaac Thomas, Anais Roger, Moutih Rafei, Katrina Gee, Sebastien Talbot, Sam Basta

Abstract readReview
In one paragraph

Review in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Isaac ThomasDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada.
Anais RogerDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada.
Moutih RafeiDepartment of Pharmacology and Physiology, Universite de Montreal, Montreal, Canada.
Katrina GeeDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada.
Sebastien TalbotDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada. sebas.talbot@gmail.com.ORCID http://orcid.org/0000-0001-9932-7174
Sam BastaDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada. bastas@queensu.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The nervous and immune systems cooperate to protect the host, yet the contribution of sensory neurons to antiviral immunity remains incompletely defined. Nociceptor neurons do more than relay pain: they detect viral products and inflammatory cues through pattern-recognition receptors (PRRs), including Toll-like receptors (TLRs) and RIG-I-like receptors (RLRs), and respond to mediators such as type I interferons (IFNs), tumor necrosis factor (TNF), and interleukin-1β (IL-1β). Upon activation, these fibres release neuropeptides and neurotransmitters, including calcitonin gene-related peptide (CGRP) and substance P (SP), while sympathetic catecholamines provide a parallel neural input that shapes vascular tone, leukocyte trafficking, and effector programmes across tissues. Viral infection can also engage neuro-glial circuits in sensory ganglia and, in some settings, spread directly to the central nervous system (CNS), as described for lymphocytic choriomeningitis virus (LCMV), herpes simplex virus (HSV), and selected influenza A virus (IAV) strains. Here, we synthesize evidence that nociceptors shape antiviral immunity in a context-dependent manner rather than exerting uniform control. Nav1.8⁺ afferents restrain excessive inflammation while supporting dendritic cell (DC) priming of CD8⁺ T cells during cutaneous HSV-1 infection; vagal TRPV1⁺ neurons, a subset of Nav1.8⁺ nociceptors, promote disease tolerance during influenza by tuning lung myeloid responses; CGRP signaling drives T helper (Th) 1 differentiation during acute LCMV infection; and sympathetic adrenergic inputs deepen CD8⁺ T cell exhaustion during chronic infection. Defining these neuro-immune circuits may reveal therapeutic opportunities, but species differences, circuit heterogeneity, and the pleiotropic effects of shared mediators will need to be resolved before these insights can be translated to human disease.

Indexed as

NociceptorsVirus DiseasesAnimalsHumansAdaptive immunityAntiviral immunityHerpes Simplex Virus (HSV)InfectionInflammationInfluenza A Virus (IAV)Innate immunityLymphocytic Choriomeningitis Virus (LCMV)Neuro-immunologyNociceptor neurons

Identifiers

PMID42015248
PMCPMC13101197

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.